Zimmer Biomet Holdings, Inc. (ZBH) Financial Statements

Income statement

Metric	TTM	2025	2024	2023	2022
Revenue
Total Revenue	8.5B	8.2B	7.7B	7.4B	6.9B
Cost of Revenue	2.6B	3.2B	2.2B	2.1B	2.0B
Gross Profit	5.9B	5.1B	5.5B	5.3B	4.9B
Operating Expenses
R&D Expense	442.9M	458.5M	437.4M	458.7M	406.0M
SG&A Expense	3.4B	3.3B	2.9B	2.8B	2.8B
General & Admin Expense	—	—	—	—	—
Selling & Marketing Expense	—	—	—	—	—
Other Expenses	736.5M	—	834.5M	735.1M	1.1B
Total Operating Expenses	4.6B	3.7B	4.2B	4.0B	4.2B
Cost and Expenses	7.2B	6.9B	6.4B	6.1B	6.2B
Operating Income (EBIT)	1.3B	1.4B	1.3B	1.3B	696.3M
Non-Operating
Interest Income	—	—	—	—	—
Interest Expense	289.0M	292.8M	218.0M	201.2M	164.8M
Net Interest Income	(289.0M)	(292.8M)	(218.0M)	(201.2M)	(164.8M)
Other Non-Op Income/Expense	(404.8M)	(531.4M)	(249.1M)	(210.4M)	(292.8M)
Non-Operating Income (excl Interest)	109.7M	238.6M	31.1M	9.2M	128.0M
EBT (Pre-Tax Income)	933.6M	830.8M	1.0B	1.1B	403.5M
Income Tax Expense	126.6M	125.7M	131.4M	42.2M	112.3M
Bottom Line
Net Income	806.8M	705.2M	903.8M	1.0B	231.4M
Earnings from Cont. Ops	807.0M	705.1M	905.2M	1.0B	291.2M
Earnings from Discont. Ops	—	—	—	—	(58.8M)
Bottom Line Net Income	806.8M	705.2M	903.8M	1.0B	231.4M
Per Share
Basic EPS	$4.13	$3.56	$4.45	$4.91	$1.10
Diluted EPS	$4.11	$3.55	$4.43	$4.88	$1.10
Revenue Per Share	$44.27	$41.57	$37.81	$35.43	$33.11
Shares
Basic Shares Outstanding	192.2M	198.0M	203.1M	208.7M	209.6M
Diluted Shares Outstanding	192.8M	198.7M	203.9M	209.7M	210.3M
Profitability Metrics
EBITDA	2.0B	2.2B	2.3B	2.2B	1.5B
D&A	729.7M	1.1B	996.3M	951.7M	926.4M
EBIT	1.2B	1.1B	1.3B	1.3B	568.3M

As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Jun 1, 2026